newsfilter
← Latest News
GlobeNewswire·

Osmotica Pharmaceuticals plc Reports Second Quarter 2021 Results and Provides Business Update

Sale of legacy business to Alora Pharmaceuticals, LLC expected to close in third quarter 2021 Second quarter 2021 total Upneeq revenue of $11.5 million including a $10.0 million milestone payment from Santen Pharmaceutical Co., Ltd Upneeq prescript